5 Best Fundamental Stocks to Buy

Page 1 of 5

In this article, we discuss the 5 best fundamental stocks to buy. If you want to read our detailed analysis of these stocks, go directly to the 11 Best Fundamental Stocks to Buy.

5. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders: 102    

Eli Lilly and Company (NYSE:LLY) develops and markets human pharmaceuticals. On November 8, investment advisory Deutsche Bank initiated coverage of Eli Lilly and Company (NYSE:LLY) stock with a Hold rating and a price target of $535.

Among the hedge funds being tracked by Insider Monkey, Florida-based investment firm GQG Partners is a leading shareholder in Eli Lilly and Company (NYSE:LLY) with 3.2 million shares worth more than $1.7 billion.  

In its Q3 2023 investor letter, RiverPark Advisors highlighted a few stocks and Eli Lilly and Company (NYSE:LLY) was one of them. Here is what the fund said:

“Eli Lilly and Company (NYSE:LLY): LLY discovers, develops, manufactures, and markets pharmaceuticals. The company manufactures and distributes products through facilities in the United States and seven other countries and sells into 110 countries. The company has a broad and deep portfolio of products including a focus on diabetes, oncology, immunology, and neuroscience. More recently, LLY’s obesity drug Mounjaro, has delivered revenue growth acceleration, and investors are optimistic that the company’s Alzheimer drug, currently in trials, will add to that growth in the future.

LLY has a stable portfolio of franchise products that enables it to invest heavily in its product pipeline. We believe that this combination of franchise and growth products will drive high teens revenue growth and a four-fold increase in free cash flow in the next five years. We initiated a small position in August.”

Page 1 of 5